Cancer Newswire (Page 3)

Comprehensive Real-Time News Feed for Cancer. (Page 3)

Results 41 - 60 of 41,811 in Cancer

  1. Redditch businessman urges communities to support Rory the Robot appealRead the original story

    6 hrs ago | Redditch Advertiser

    ... But a routine blood test threw up some shattering news - he had raised Prostate-Specific Antigen levels and prostate cancer. "I had no symptoms and it was only as a result of moving home it was picked up in my case," he said. In May 2014 Ian, who ...

    Comment?

  2. Younger Cancer Patients More Open To Alternative TherapiesRead the original story w/Photo

    7 hrs ago | Medical Daily

    Cancer patients under age 65 are much more likely than older people to explore alternative and complementary medicine for easing their symptoms and side effects of treatment, a new study suggests. "We found that the baby boomers are much more likely to use complimentary and alternative therapies than their parents in part due to a social change in the U.S. in the 60s and 70s with a big social movement toward things like a macrobiotic diet and yoga that made these things more mainstream," said senior study author Dr. Jun Mao, director of integrated oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia.

    Comment?

  3. Nunavut teens go online to fund-raise for world female hockey festRead the original story w/Photo

    8 hrs ago | Nunatsiaq News

    ... online for their 2015 grad trip(only to have their planned trip axed by education officials at the last minute.) cancer patient Janice Simailak of Baker Lake, who recently reached out on GoFundMe because she is not receiving any Government of ...

    Comment?

  4. New Study: Priaxon AG - Pharmaceuticals & Healthcare - Deals and Alliances ProfileRead the original story

    8 hrs ago | PR-inside.com

    ... products include GSK, Mcl1, MDMX, Bcl-6 and HpGT. The company develops MDM2-p53 inhibitor for the treatment for cancer. It develops apoptotic modulators for radio- and chemoprotective applications during cancer therapy and it also identifies MCL1 ...

    Comment?

  5. Americans Can't Buy Some of the Best SunscreensRead the original story w/Photo

    8 hrs ago | Kansas City InfoZine

    But across the Atlantic, Europeans will be slathering on formulations that manufacturers say provide better protection against the sun's damaging rays - and skin cancer - than what's available stateside, according to an article in Chemical & Engineering News , the weekly newsmagazine of the American Chemical Society. Marc S. Reisch, a senior correspondent at C&EN, reports that sunscreens on the U.S. market do protect users from some ultraviolet-A and -B rays.

    Comment?

  6. Hey, it's me...Kathy: Cancer marker numbers continue to decreaseRead the original story

    8 hrs ago | Truro Daily News

    ... not in the low range anymore. Hopefully my fingernails will start to grow and get harder. The doctor told me that my cancer markers are at 15, that's a big woo-hoo. That means this drug is working and I will be able to stay on this chemo. Before I ...

    Comment?

  7. ACT.md Drives Healthcare Team Efficiency Through InteroperabilityRead the original story

    9 hrs ago | Customer Interaction Solutions

    On The hypothetical colon cancer patient's journey will begin with initial symptoms and progress through family history and risk assessment, genomic testing, surgery, chemotherapy administration, and home care. The patient's health activities and clinical information will be documented in real time and transmitted to receiving applications using internationally recognized interoperability standards.

    Comment?

  8. Cancer diagnoses in Quebec to jump 35% by 2030: reportRead the original story w/Photo

    9 hrs ago | Canada.com

    ... from a beach in Tofino last summer will remain at the Vancouver Aquarium. FAYETTEVILLE, NC - JUNE 17: A breast cancer patient receives a chemotherapy drip at Cape Fear Valley Medical Center June 17, 2003 in Fayetteville, North Carolina. Innovations ...

    Comment?

  9. How Herpes Cells Are Being Used to Fight CancerRead the original story w/Photo

    9 hrs ago | TIME.com

    Patients who used cells from this STD to treat their melanoma were 8 times more likely to survive than a control group A genetically modified strain of herpes can kill cancer cells and stop tumors from growing, according to new research. The strain, called T-Vec, was used to treat patients with melanoma as part of one of the final phases of testing of a new drug.

    Comment?

  10. 3D printer generates realistic model of a cancerous tumourRead the original story w/Photo

    10 hrs ago | PhysOrg Weblog

    ... journal Biofabrication , the realistic 3D model consists of a scaffold of fibrous proteins coated in cervical cancer cells. A 10mm by 10mm grid structure - made from gelatin, alginate and fibrin - recreates the fibrous proteins that make up the ...

    Comment?

  11. Study finds association between exposure to aflatoxin and gallbladder cancerRead the original story

    10 hrs ago | Medical News Today

    In a small study in Chile that included patients with gallbladder cancer , exposure to aflatoxin was associated with an increased risk of gallbladder cancer, according to a study in JAMA . In Chile, gallbladder cancer is a leading cause of cancer death in women.

    Comment?

  12. Newly formed cancer support group to host first meetingRead the original story

    10 hrs ago | Chino Valley Review

    Cancer survivors, caregivers and providers are coming together to form a Cancer Support Group for people throughout our communities. The Cancer Support Group - which will be run by its participants - will hold its first meeting on Wednesday, June 17, 4-5 p.m. at the Adult Center of Prescott, 1280 Rosser Street in Prescott.

    Comment?

  13. Genomic Health to Present at the Jefferies 2015 Global Healthcare ConferenceRead the original story

    10 hrs ago | Freshnews

    ... provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise ...

    Comment?

  14. Innocrin Pharmaceuticals, Inc. Initiates Phase 2 Castration-Resistant ...Read the original story

    10 hrs ago | Freshnews

    Innocrin Pharmaceuticals, Inc. Initiates Phase 2 Castration-Resistant Prostate Cancer Study in Men Who Have Failed Enzalutmaide or Abiraterone RESEARCH TRIANGLE PARK, N.C. -- -- Innocrin Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing small-molecule CYP17 lyase-selective inhibitors for the treatment of hormonally-dependent breast and prostate cancers resistant to standard hormonal therapy, today announced the initiation of a new Phase 2 study: Once-daily Oral VT-464 in Patients With CRPC Progressing on Enzalutamide or Abiraterone .

    Comment?

  15. Tanning Beds And College Campuses - A Public Health ConcernRead the original story

    11 hrs ago | KRMG-AM Tulsa

    ... have become dermatologists' favorite bad guy. But some policymakers say that's not enough. Pointing to rising skin cancer rates and increased marketing toward young people, these public health advocates want new national restrictions regarding who ...

    Comment?

  16. In Recognition of National Melanoma Awareness Month, Beauty Guru...Read the original story w/Photo

    14 hrs ago | PRWeb

    Skin expert and founder of the award-winning skin clinic FACE Skincare~Medical~Wellness, Holly CaSaroll, is detailing ways of decreasing the risk of skin cancer and premature aging. Holly CaSaroll, founder of FACE, the award-winning beauty clinic, is detailing several tips on preventing burns, aging and cancer.

    Comment?

  17. AbbVie Completes Pharmacyclics AcquisitionRead the original story w/Photo

    15 hrs ago | Contract Pharma Breaking News

    ... shared expertise, combined with AbbVie's broad late-stage oncology pipeline, has the potential to transform the cancer treatment landscape for hematological malignancies and improve patient outcomes and quality of life," said Richard A. Gonzalez, ...

    Comment?

  18. Why Americans can't buy some of the best sunscreensRead the original story w/Photo

    18 hrs ago | EurekAlert!

    With summer nearly here, U.S. consumers might think they have an abundance of sunscreen products to choose from. But across the Atlantic, Europeans will be slathering on formulations that manufacturers say provide better protection against the sun's damaging rays -- and skin cancer -- than what's available stateside, according to an article in Chemical & Engineering News , the weekly newsmagazine of the American Chemical Society.

    Comment?

  19. Study could explain why ovarian cancer treatments failRead the original story w/Photo

    18 hrs ago | EurekAlert!

    Professor Sean Grimmond, from The University of Queensland's Institute for Molecular Bioscience, said ovarian cancer cells had at least four different ways to avoid being destroyed by platinum-based chemotherapy treatments. "This is fundamentally different to other cancers where the disease is driven by smaller but more gradual changes to individual genes.

    Comment?

  20. Editas Medicine, Juno Therapeutics Hammer Out $727 Million Car T R&D DealRead the original story

    23 hrs ago | BioSpace

    SEATTLE & CAMBRIDGE, Mass.-- --Juno Therapeutics, Inc., a leading biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and Editas Medicine, a leader in genome editing, today announced an exclusive collaboration focused on creating chimeric antigen receptor and high-affinity T cell receptor therapies to treat cancer. The companies will pursue three research programs together utilizing Editas' genome editing technologies, including CRISPR/Cas9, with Juno's CAR and TCR technologies.

    Comment?